These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Plasma catecholamines and hemodynamic responses to stress states in man. Halter JB; Stratton JR; Pfeifer MA Acta Physiol Scand Suppl; 1984; 527():31-8. PubMed ID: 6589949 [TBL] [Abstract][Full Text] [Related]
27. The effect of doxazosin on platelet aggregation in normotensive subjects and patients with hypertension: an in vitro study. Hernandez Hernandez R; Carvajal AR; Guerrero Pajuelo J; Armas de Hernandez MJ; Armas Padilla MC; Barragan O; Boada Boada JJ; Roa E Am Heart J; 1991 Jan; 121(1 Pt 2):389-94. PubMed ID: 1824665 [TBL] [Abstract][Full Text] [Related]
28. The effect of prazosin therapy on platelet activation in essential hypertension. Okrucká A; Pechán J; Mikulecký M Clin Exp Pharmacol Physiol; 1990 Dec; 17(12):813-9. PubMed ID: 2151184 [TBL] [Abstract][Full Text] [Related]
29. Effects of prazosin on platelet aggregation and plasma beta-thromboglobulin in essential hypertension. Ikeda T; Nonaka Y; Goto A; Ishii M Clin Pharmacol Ther; 1985 Jun; 37(6):601-5. PubMed ID: 2408807 [TBL] [Abstract][Full Text] [Related]
30. Norepinephrine-induced human platelet activation in vivo is only partly counteracted by aspirin. Larsson PT; Wallén NH; Hjemdahl P Circulation; 1994 May; 89(5):1951-7. PubMed ID: 8181117 [TBL] [Abstract][Full Text] [Related]
31. The role of catecholamines, age, and fitness on blood pressure reactivity to dynamic exercise in patients with essential hypertension. Braun LT; Potempa K; Holm K; Fogg L; Szidon JP Heart Lung; 1994; 23(5):404-12. PubMed ID: 7989209 [TBL] [Abstract][Full Text] [Related]
32. Borderline hypertension: relationship between age, hemodynamics and circulating catecholamines. Messerli FH; Frohlich ED; Suarez DH; Reisin E; Dreslinski GR; Dunn FG; Cole FE Circulation; 1981 Oct; 64(4):760-4. PubMed ID: 7273377 [TBL] [Abstract][Full Text] [Related]
33. [Arterial hypertension. Density of alpha 1 and alpha 2 adrenergic receptors in blood platelets, beta adrenergic receptors in the lymphocytes and serum catecholamine levels]. Halawa B Kardiol Pol; 1991; 35(12):340-4. PubMed ID: 1666134 [TBL] [Abstract][Full Text] [Related]
34. Red blood cell catecholamine levels in normotensive and DOCA-salt hypertensive rats. Bouvier M; Farley L; de Champlain J Am J Physiol; 1987 Aug; 253(2 Pt 2):H270-5. PubMed ID: 3618801 [TBL] [Abstract][Full Text] [Related]
35. Platelet aggregation, blood viscosity and serum lipids in hypertensive and obese children. Haszon I; Papp F; Kovács J; Bors M; Németh I; Bereczki C; Túri S Eur J Pediatr; 2003 Jun; 162(6):385-90. PubMed ID: 12684895 [TBL] [Abstract][Full Text] [Related]
36. Beta-thromboglobulin and platelet aggregation in essential hypertension and the influence of prazosin therapy. Okrucká A; Pechán J; Mikulecký M Cor Vasa; 1990; 32(5):363-73. PubMed ID: 2149548 [TBL] [Abstract][Full Text] [Related]
39. The relationship between potassium balance and circulating catecholamines in essential hypertension. Cerasola G; Morici ML; Cottone S; Grasso L; D'Ignoto G Boll Soc Ital Biol Sper; 1984 Jun; 60(6):1111-7. PubMed ID: 6477727 [TBL] [Abstract][Full Text] [Related]
40. Effect of systemic alpha-2 adrenergic blockade on the morning increase in platelet aggregation in normal subjects. Andrews NP; Goldstein DS; Quyyumi AA Am J Cardiol; 1999 Aug; 84(3):316-20. PubMed ID: 10496442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]